| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
24,353 |
16,808 |
$6.45M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
28,324 |
20,102 |
$5.35M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,226 |
4,473 |
$2.42M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,692 |
11,581 |
$1.09M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,557 |
11,043 |
$861K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
9,257 |
7,120 |
$839K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,313 |
927 |
$403K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,135 |
2,727 |
$282K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,085 |
1,524 |
$224K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,158 |
1,586 |
$191K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,561 |
2,081 |
$180K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
849 |
535 |
$169K |
| 99215 |
Prolong outpt/office vis |
1,457 |
1,025 |
$124K |
| 99205 |
Prolong outpt/office vis |
932 |
679 |
$123K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,480 |
1,271 |
$105K |
| 80053 |
Comprehensive metabolic panel |
20,681 |
17,499 |
$104K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20,331 |
17,140 |
$79K |
| 95886 |
|
381 |
245 |
$78K |
| 71045 |
Radiologic examination, chest; single view |
2,669 |
1,824 |
$78K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,443 |
2,061 |
$72K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,100 |
3,523 |
$60K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
5,345 |
4,267 |
$53K |
| 73630 |
|
1,646 |
947 |
$53K |
| 20610 |
|
1,062 |
554 |
$51K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,451 |
1,226 |
$44K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,463 |
1,183 |
$41K |
| 01810 |
|
207 |
182 |
$33K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
831 |
561 |
$29K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
402 |
359 |
$29K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,151 |
1,116 |
$26K |
| 64721 |
|
26 |
13 |
$24K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
587 |
486 |
$23K |
| 71046 |
Radiologic examination, chest; 2 views |
173 |
163 |
$22K |
| J2704 |
Injection, propofol, 10 mg |
921 |
819 |
$22K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
221 |
199 |
$19K |
| 87631 |
|
177 |
170 |
$17K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
306 |
285 |
$16K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
131 |
118 |
$14K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,703 |
1,537 |
$14K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
468 |
375 |
$13K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
33 |
24 |
$13K |
| 81001 |
|
6,117 |
5,289 |
$11K |
| 83605 |
|
2,051 |
1,692 |
$11K |
| 95910 |
|
85 |
52 |
$10K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
712 |
678 |
$10K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
133 |
115 |
$10K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,940 |
1,765 |
$9K |
| 80061 |
Lipid panel |
1,348 |
1,232 |
$8K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
606 |
419 |
$8K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
237 |
156 |
$8K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
80 |
49 |
$8K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
249 |
221 |
$8K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
307 |
273 |
$7K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
813 |
666 |
$7K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
61 |
54 |
$6K |
| 76857 |
|
115 |
55 |
$6K |
| 84484 |
|
1,332 |
885 |
$6K |
| 69210 |
|
182 |
101 |
$5K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
13 |
12 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
175 |
151 |
$5K |
| 86850 |
|
460 |
439 |
$5K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
29 |
12 |
$5K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
117 |
97 |
$5K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
23 |
13 |
$4K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
106 |
90 |
$4K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
48 |
13 |
$4K |
| 95816 |
|
24 |
12 |
$4K |
| 59025 |
Fetal non-stress test |
54 |
13 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
144 |
134 |
$4K |
| 95800 |
|
16 |
12 |
$4K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
286 |
245 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
34 |
25 |
$3K |
| 31231 |
|
22 |
12 |
$3K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
12 |
12 |
$3K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
19 |
15 |
$3K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
163 |
153 |
$3K |
| 92567 |
|
89 |
62 |
$3K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
96 |
41 |
$3K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
101 |
94 |
$3K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
59 |
58 |
$3K |
| 85027 |
|
670 |
619 |
$2K |
| 95115 |
|
215 |
77 |
$2K |
| J7050 |
Infusion, normal saline solution, 250 cc |
146 |
55 |
$2K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
28 |
12 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
30 |
14 |
$2K |
| 11102 |
|
12 |
12 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
80 |
79 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
80 |
79 |
$2K |
| 00142 |
|
18 |
12 |
$2K |
| 73564 |
|
77 |
40 |
$2K |
| 95117 |
|
76 |
25 |
$2K |
| 20553 |
|
226 |
130 |
$2K |
| 83735 |
|
473 |
406 |
$2K |
| 83690 |
|
376 |
332 |
$2K |
| 81025 |
|
260 |
258 |
$1K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
58 |
31 |
$1K |
| 80306 |
|
144 |
133 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
431 |
355 |
$1K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
12 |
12 |
$1K |
| 73110 |
|
76 |
40 |
$1K |
| 73130 |
|
68 |
40 |
$1K |
| C1780 |
Lens, intraocular (new technology) |
18 |
12 |
$1K |
| 92588 |
|
16 |
12 |
$1K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
34 |
30 |
$1K |
| 87400 |
|
174 |
83 |
$1K |
| 84145 |
|
137 |
114 |
$1K |
| 87081 |
|
219 |
213 |
$1K |
| 95885 |
|
23 |
12 |
$1K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
31 |
27 |
$938.59 |
| 11721 |
|
72 |
53 |
$931.18 |
| 99406 |
|
64 |
58 |
$925.65 |
| 73610 |
|
65 |
31 |
$880.92 |
| 86140 |
|
386 |
346 |
$826.17 |
| 81002 |
|
457 |
418 |
$814.11 |
| 92504 |
|
20 |
14 |
$700.78 |
| 87634 |
|
13 |
12 |
$683.84 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
162 |
152 |
$662.63 |
| 73030 |
|
30 |
15 |
$634.29 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
64 |
64 |
$628.29 |
| 86803 |
|
59 |
51 |
$449.55 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
12 |
12 |
$434.64 |
| 87806 |
|
12 |
12 |
$407.50 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
26 |
26 |
$387.78 |
| 93244 |
|
14 |
13 |
$366.45 |
| 85652 |
|
314 |
287 |
$365.11 |
| 86780 |
|
38 |
38 |
$342.11 |
| 20552 |
|
100 |
71 |
$327.13 |
| 85610 |
|
159 |
137 |
$282.09 |
| 86900 |
|
137 |
135 |
$278.52 |
| 86901 |
|
137 |
135 |
$274.34 |
| 85730 |
|
75 |
71 |
$263.67 |
| 93227 |
|
13 |
12 |
$258.10 |
| 87340 |
|
37 |
37 |
$256.99 |
| 93296 |
|
12 |
12 |
$233.74 |
| 86762 |
|
25 |
25 |
$231.61 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
13 |
12 |
$228.06 |
| 82728 |
|
27 |
26 |
$209.88 |
| 85379 |
|
20 |
17 |
$201.64 |
| 83880 |
|
17 |
12 |
$191.67 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
14 |
13 |
$177.63 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
13 |
$157.68 |
| 81003 |
|
123 |
120 |
$149.99 |
| 82607 |
|
24 |
21 |
$147.84 |
| 83550 |
|
30 |
28 |
$141.63 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
18 |
12 |
$130.30 |
| 85018 |
|
65 |
65 |
$102.92 |
| 83540 |
|
30 |
28 |
$99.66 |
| 84439 |
|
12 |
12 |
$75.72 |
| 82570 |
|
15 |
13 |
$25.41 |
| 82043 |
|
12 |
12 |
$24.30 |
| 99024 |
|
700 |
549 |
$0.00 |
| A9270 |
Non-covered item or service |
28 |
13 |
$0.00 |